NewGenIvf Group (NIVF) Competitors $0.55 0.00 (-0.87%) Closing price 04:00 PM EasternExtended Trading$0.54 0.00 (-0.73%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. MGRX, SSY, BGLC, VSEE, ATIP, DHAC, ACON, OTRK, BACK, and BTTXShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), VSee Health (VSEE), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), Aclarion (ACON), Ontrak (OTRK), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Its Competitors Mangoceuticals SunLink Health Systems BioNexus Gene Lab VSee Health ATI Physical Therapy Digital Health Acquisition Aclarion Ontrak IMAC Better Therapeutics Mangoceuticals (NASDAQ:MGRX) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings. Do institutionals and insiders hold more shares of MGRX or NIVF? 56.7% of Mangoceuticals shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor MGRX or NIVF? In the previous week, NewGenIvf Group had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 2 mentions for NewGenIvf Group and 1 mentions for Mangoceuticals. Mangoceuticals' average media sentiment score of 0.00 equaled NewGenIvf Group'saverage media sentiment score. Company Overall Sentiment Mangoceuticals Neutral NewGenIvf Group Neutral Which has more risk & volatility, MGRX or NIVF? Mangoceuticals has a beta of 2.4, indicating that its stock price is 140% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.03, indicating that its stock price is 103% less volatile than the S&P 500. Which has better earnings and valuation, MGRX or NIVF? NewGenIvf Group has higher revenue and earnings than Mangoceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$620K14.59-$8.71M-$4.64-0.38NewGenIvf Group$5.43M0.44-$520KN/AN/A Is MGRX or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to Mangoceuticals' net margin of -2,191.76%. NewGenIvf Group's return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-2,191.76% -72.81% -66.58% NewGenIvf Group N/A N/A N/A SummaryNewGenIvf Group beats Mangoceuticals on 8 of the 10 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.39M$7.21B$5.70B$9.48BDividend YieldN/A2.80%4.59%3.99%P/E RatioN/A25.2027.9019.95Price / Sales0.4441.42442.19102.72Price / CashN/A28.2736.5558.97Price / Book-0.029.698.635.90Net Income-$520K$239.98M$3.24B$258.42M7 Day Performance-9.87%1.50%3.22%1.94%1 Month Performance-49.26%5.63%10.72%12.02%1 Year Performance-99.73%17.99%34.94%20.81% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf GroupN/A$0.55-0.9%N/A-99.7%$2.39M$5.43M0.00N/AMGRXMangoceuticals0.4219 of 5 stars$1.46-3.9%N/A-98.2%$7.55M$511.08K-0.313SSYSunLink Health Systems2.7106 of 5 stars$0.97+0.4%N/A+37.2%$6.86M$31.09M6.961,376News CoverageDividend AnnouncementBGLCBioNexus Gene Lab0.4691 of 5 stars$3.69-7.2%N/A+4.0%$6.66M$9.51M0.0030Gap DownVSEEVSee Health0.5562 of 5 stars$1.33-3.6%$5.00+275.9%-61.8%$4.86MN/A0.00N/AGap DownATIPATI Physical TherapyN/A$1.03flatN/A-94.1%$4.54M$741.86M-0.065,600DHACDigital Health AcquisitionN/A$1.22+3.4%N/A-64.1%$4.40MN/A0.002,021ACONAclarion2.2332 of 5 stars$7.28-0.7%$11,758.50+161,417.9%-99.7%$4.24M$54.60K0.007Gap DownOTRKOntrak2.2506 of 5 stars$0.49+0.6%$24.00+4,798.0%-85.2%$2.09M$10.85M-0.03250Gap UpBACKIMACN/A$0.06-20.4%N/A-95.8%$133K$72.05K0.00180Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/A-66.7%$5KN/A0.0040 Related Companies and Tools Related Companies Mangoceuticals Alternatives SunLink Health Systems Alternatives BioNexus Gene Lab Alternatives VSee Health Alternatives ATI Physical Therapy Alternatives Digital Health Acquisition Alternatives Aclarion Alternatives Ontrak Alternatives IMAC Alternatives Better Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NIVF Stock Alerts